Unknown NA INTERVENTIONAL 1-arm NCT03249025

Lidocaine-Ketamine for Management of Chronic Pain

Ambulatory Infusion of Lidocaine and Ketamine for Management of Chronic Pain: An Observational Prospective Study

Sponsor: Hamilton Health Sciences Corporation

Updated 5 times since 2017 Last updated: Aug 10, 2017 Started: Sep 1, 2017 Primary completion: Sep 1, 2018 Completion: Sep 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Chronic Pain Syndrome, this trial is ongoing. The trial is conducted by Hamilton Health Sciences Corporation and has accumulated 5 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Sep 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Sep 2017 — Sep 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hamilton Health Sciences Corporation

Data source: Hamilton Health Sciences Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.